Serum YKL-40 levels as a novel marker of inflammation in patients with endometriosis

Ülkü Mete Ural, Ural UM, U Mete Ural, Yücel Tekìn, Tekin YB, Y Bayoğlu Tekin, Cüre M, M.C. Cure, M Cüre, F. Kir Şahin Şahin, F Kir Şahin, Şahin FK
Clinical and experimental obstetrics & gynecology · 2015 · vol. 42(4) , pp. 495–497 · doi:10.12891/ceog1882.2015 · PMID:26411218 · W2316791087
Observational OA: bronze CC0 ⤵ 8 in-corpus citations
🔓 Open OA copy Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Serum YKL-40 levels were significantly elevated in patients with endometriosis compared to healthy controls, suggesting its potential as a novel biomarker.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text ⓘ

This cross-sectional study compared serum YKL-40 concentrations between 33 endometriosis patients and 30 age-matched healthy controls recruited from a tertiary care center. Serum YKL-40 was measured using an ELISA kit, and demographics and YKL-40 levels were recorded. The authors found higher mean serum YKL-40 levels in the endometriosis group than in controls (106.0 ± 15.9 vs 52.2 ± 7.0; p = 0.003). The paper’s limitation is that the design does not establish causality, and it does not evaluate diagnostic performance or longitudinal changes; it remains based on this single assessment. This paper is centrally about endometriosis — it evaluates serum YKL-40 as an inflammation-related biomarker in patients with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: To establish serum YKL-40 concentrations in patients with endometriosis compared to age-matched healthy subjects. MATERIALS AND METHODS: This was a cross-sectional clinical study conducted in a tertiary care center. Demographics and serum YKL levels were determined and noted in a total of 63 cases (33 endometriosis patients, 30 healthy controls). Measurement of YKL-40 levels was made using a YKL-40 enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer's protocol. RESULTS: The mean serum YKL-40 levels of the patient group was 106.0 +/- 15.9 (range 23.44 to 382.55) years, while the mean serum YKL-40 levels of the controls was 52.2 +/- 7.0 (range 22.35 to 160.0) years (p = 0.003). CONCLUSIONS: This is the first study evaluating serum YKL-40 levels in endometriosis. The present results indicate that YKL-40 levels were increased in patients with endometriosis compared to controls. The authors propose that circulating YKL-40 levels could be a novel biomarker for diagnosis and follow-up of endometriosis.
Full text 1,698 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Purpose: To establish serum YKL-40 concentrations in patients with endometriosis compared to age-matched healthy subjects. Materials and Methods: This was a cross-sectional clinical study conducted in a tertiary care center. Demographics and serum YKL levels were determined and noted in a total of 63 cases (33 endometriosis patients, 30 healthy controls). Measurement of YKL-40 levels was made using a YKL-40 enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer’s protocol. Results: The mean serum YKL-40 levels of the patient group was 106.0 ± 15.9 (range 23.44 to 382.55) years, while the mean serum YKL-40 levels of the controls was 52.2 ± 7.0 (range 22.35 to 160.0) years (p = 0.003). Conclusions: This is the first study evaluating serum YKL-40 levels in endometriosis. The present results indicate that YKL-40 levels were increased in patients with endometriosis compared to controls. The authors propose that circulating YKL-40 levels could be a novel biomarker for diagnosis and follow-up of endometriosis.

Keywords

- Endometriosis - Serum - YKL-40 levels - Marker

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adipokines Biomarkers Endometriosis Lectins Adipokines Adipokines Adipokines Adult Adult Biomarkers Biomarkers Case-Control Studies Case-Control Studies Chitinase-3-Like Protein 1 Chitinase-3-Like Protein 1 Cross-Sectional Studies Cross-Sectional Studies Endometriosis Endometriosis Enzyme-Linked Immunosorbent Assay

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (27)

Cited by (7)

Source provenance

europepmc
last seen: 2026-10-22T06:08:12.857683+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:16:31.290043+00:00
License: CC0 · commercial use OK